Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Non-Current Debt (2022 - 2025)

Rxo (RXO) has disclosed Non-Current Debt for 4 consecutive years, with $387.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Debt rose 10.26% year-over-year to $387.0 million, compared with a TTM value of $387.0 million through Dec 2025, up 10.26%, and an annual FY2025 reading of $387.0 million, up 10.26% over the prior year.
  • Non-Current Debt was $387.0 million for Q4 2025 at Rxo, roughly flat from $387.0 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $451.0 million in Q4 2022 and bottomed at $6.0 million in Q3 2022.
  • Average Non-Current Debt over 4 years is $367.0 million, with a median of $387.0 million recorded in 2025.
  • The sharpest move saw Non-Current Debt surged 7416.67% in 2023, then dropped 22.17% in 2024.
  • Year by year, Non-Current Debt stood at $451.0 million in 2022, then decreased by 21.06% to $356.0 million in 2023, then dropped by 1.4% to $351.0 million in 2024, then rose by 10.26% to $387.0 million in 2025.
  • Business Quant data shows Non-Current Debt for RXO at $387.0 million in Q4 2025, $387.0 million in Q3 2025, and $387.0 million in Q2 2025.